Adherence to a Mediterranean lifestyle improves metabolic status in coronary heart disease patients: A prospective analysis from the CORDIOPREV study.

BACKGROUND AND OBJECTIVES: A Mediterranean lifestyle may prevent and mitigate cardiometabolic disorders. We explored whether adherence to a Mediterranean lifestyle was prospectively associated with the risk of metabolic syndrome (MetS) among coronary heart disease (CHD) patients. METHODS: The Coronary Diet Intervention with Olive Oil and Cardiovascular Prevention (CORDIOPREV) study was an interventional diet study to compare a Mediterranean diet with a low-fat diet, in 1002 CHD patients. The Mediterranean lifestyle (MEDLIFE) index was used to assess adherence to a MEDLIFE at baseline, and after 5 years, in 851 participants from the CORDIOPREV study. Subjects were classified as having high (>13 points), moderate (12-13 points), and low (<12 points) adherence to the MEDLIFE. Multivariable logistic regression models were used to determine the association between MEDLIFE adherence and the risk of MetS development or reversal. RESULTS: During the 5-year follow-up, CORDIOPREV participants with high adherence to MEDLIFE had a lower risk of MetS development (odds ratio [OR] 0.37, 95% confidence interval [CI] 0.19-0.75, p < 0.01) and a higher likelihood of reversing preexisting MetS (OR 2.08 CI 95% 1.11-3.91, p = 0.02) compared with participants in the low MEDLIFE adherence group. Each additional one-point increment in the MEDLIFE index was associated with a 24% lower risk of MetS development (OR 0.76, 95% CI 0.64-0.90, p < 0.01) and a 21% higher likelihood of reversing preexisting MetS (OR 1.21 CI 95% 1.04-1.41, p = 0.01). CONCLUSIONS: Our results showed that greater adherence to a MEDLIFE reduced the risk of subsequent MetS development and increased the likelihood of reversing preexisting MetS among patients with CHD at baseline.

Daylight Saving Time transitions and Cardiovascular Disease in Andalusia: Time Series Modeling and Analysis Using Visibility Graphs.

The present study aimed to determine whether transitions both to and from daylight saving time (DST) led to an increase in the incidence of hospital admissions for major acute cardiovascular events (MACE). To support the analysis, natural visibility graphs (NVGs) were used with data from Andalusian public hospitals between 2009 and 2019. We calculated the incidence rates of hospital admissions for MACE, and specifically acute myocardial infarction and ischemic stroke during the 2 weeks leading up to, and 2 weeks after, the DST transition. NVG were applied to identify dynamic patterns. The study included 157 221 patients diagnosed with MACE, 71 992 with AMI (42 975 ST-elevation myocardial infarction (STEMI) and 26 752 non-ST-elevation myocardial infarction (NSTEMI)), and 51 420 with ischemic stroke. Observed/expected ratios shown an increased risk of AMI (1.06; 95% CI (1.00-1.11); P = .044), NSTEMI (1.12; 95% CI (1.02-1.22); P = .013), and acute coronary syndrome (1.05; 95% CI (1.00-1.10); P = .04) around the autumn DST. The NVG showed slight variations in the daily pattern of pre-DST and post-DST hospitalization admissions for all pathologies, but indicated that the increase in the incidence of hospital admissions after the DST is not sufficient to change the normal pattern significantly.

A plasma fatty acid profile associated to type 2 diabetes development: from the CORDIOPREV study.

PURPOSE: The prevalence of type 2 diabetes mellitus (T2DM) is increasing worldwide. For this reason, it is essential to identify biomarkers for the early detection of T2DM risk and/or for a better prognosis of T2DM. We aimed to identify a plasma fatty acid (FA) profile associated with T2DM development. METHODS: We included 462 coronary heart disease patients from the CORDIOPREV study without T2DM at baseline. Of these, 107 patients developed T2DM according to the American Diabetes Association (ADA) diagnosis criteria after a median follow-up of 60 months. We performed a random classification of patients in a training set, used to build a FA Score, and a Validation set, in which we tested the FA Score. RESULTS: FA selection with the highest prediction power was performed by random survival forest in the Training set, which yielded 4 out of the 24 FA: myristic, petroselinic, α-linolenic and arachidonic acids. We built a FA Score with the selected FA and observed that patients with a higher score presented a greater risk of T2DM development, with an HR of 3.15 (95% CI 2.04-3.37) in the Training set, and an HR of 2.14 (95% CI 1.50-2.84) in the Validation set, per standard deviation (SD) increase. Moreover, patients with a higher FA Score presented lower insulin sensitivity and higher hepatic insulin resistance (p < 0.05). CONCLUSION: Our results suggest that a detrimental FA plasma profile precedes the development of T2DM in patients with coronary heart disease, and that this FA profile can, therefore, be used as a predictive biomarker. CLINICAL TRIALS.GOV. IDENTIFIER: NCT00924937.

Schwannoma intraparenquimatoso con calcificación focal en lóbulo temporal. Reporte de caso y revisión de literatura / Intraparenchymal schwannoma with focal calcification in the temporal lobe. Case report and literature review

Los schwannomas intraparenquimatosos son tumores con una muy baja incidencia en el sistema nervioso central. Actualmente, no se conoce su verdadero origen. Sin embargo, con el paso de los años se han descripto múltiples teorías. Son tumores que afectan principalmente a niños y adultos jóvenes. El síntoma principal es la cefalea; y se ubican principalmente en el compartimiento supratentorial. El Gold Standard para su estudio es la resonancia magnética donde suelen presentarse como lesiones hipointensas en T1, hiperintensas en T2 que captan contraste de forma homogénea. Una vez diagnosticado debe plantearse la resolución quirúrgica ya que en la mayoría de los casos representan una lesión benigna, y su exéresis completa significa la resolución de la enfermedad. El diagnóstico definitivo se obtiene mediante la anatomía patológica. A continuación, presentaremos el caso de una paciente de 46 años con antecedente de cefalea en cuyo contexto, mediante una resonancia magnética, se descubre una lesión en el lóbulo temporal siendo el diagnóstico de la misma: schwannoma intraparenquimatoso con calcificación focal

Intraparenchymal schwannomas have a very low incidence in the central nervous system. Currently, its true origin is not known, however, over the years, multiple theories have been described. This pathology mainly affects children and young adults. The main symptom is headache; and usually it is located in the supratentorial compartment. The Gold Standard is MRI where they usually present as hypointense lesions in T1, hyperintense in T2 that capture contrast in a homogeneous way. Once diagnosed, surgical resolution should be considered, since in most cases they represent a benign lesion, and their complete excision means resolution of the disease. The definitive diagnosis is obtained by pathological anatomy. We present a case of a 46-year-old patient with history of headache, its magnetic resonance revealed an extra axial lesion in the temporal lobe with considerable surrounding edema, the diagnosis was Intraparenchymal schwannoma with focal calcification in the temporal lobe

miR-223-3p as a potential biomarker and player for adipose tissue dysfunction preceding type 2 diabetes onset.

Circulating microRNAs (miRNAs) have been proposed as biomarkers for type 2 diabetes (T2D). Adipose tissue (AT), for which dysfunction is widely associated with T2D development, has been reported as a major source of circulating miRNAs. However, the role of dysfunctional AT in the altered pattern of circulating miRNAs associated with T2D onset remains unexplored. Herein, we investigated the relationship between T2D-associated circulating miRNAs and AT function, as well as the role of preadipocytes and adipocytes as secreting cells of candidate circulating miRNAs. Among the plasma miRNAs related to T2D onset in the CORonary Diet Intervention with Olive oil and cardiovascular PREVention (CORDIOPREV) cohort, baseline miR-223-3p levels (diminished in patients who next developed T2D [incident-T2D]) were significantly related to AT insulin resistance (IR). Baseline serum from incident-T2D participants induced inflammation and IR in 3T3-L1 adipocytes. We demonstrated that tumor necrosis factor (TNF)-α inhibited miR-223-3p secretion while enhancing miR-223-3p intracellular accumulation in 3T3-L1 (pre)adipocytes. Overexpression studies showed that an intracellular increase of miR-223-3p impaired glucose and lipid metabolism in these cells. Our findings provide mechanistic insights into the alteration of circulating miRNAs preceding T2D, unveiling both preadipocytes and adipocytes as miR-223-3p-secreting cells and suggesting that inflammation promotes miR-223-3p intracellular accumulation, which might contribute to (pre)adipocyte dysfunction and body metabolic dysregulation.

A set of miRNAs predicts T2DM remission in patients with coronary heart disease: from the CORDIOPREV study.

MicroRNAs (miRNAs) regulate the expression of genes associated with the development of diseases, including type 2 diabetes mellitus (T2DM). However, the use of miRNAs to predict T2DM remission has been poorly studied. Therefore, we aimed to investigate whether circulating miRNAs could be used to predict the probability of T2DM remission in patients with coronary heart disease. We included the newly diagnosed T2DM (n = 190) of the 1,002 patients from the CORDIOPREV study. Seventy-three patients reverted from T2DM after 5 years of dietary intervention with a low-fat or Mediterranean diet. Plasma levels of 56 miRNAs were measured by OpenArray. Generalized linear model, receiver operating characteristic (ROC), Cox regression, and pathway analyses were performed. ROC analysis based on clinical variables showed an area under the curve (AUC) of 0.66. After a linear regression analysis, seven miRNAs were identified as the most important variables in the group's differentiation. The addition of these miRNAs to clinical variables showed an AUC of 0.79. Cox regression analysis using a T2DM remission score including miRNAs showed that high-score patients have a higher probability of T2DM remission (hazard ratio [HR]low versus high, 4.44). Finally, 26 genes involved in 10 pathways were related to the miRNAs. We have identified miRNAs (hsa-let-7b, hsa-miR-101, hsa-miR-130b-3p, hsa-miR-27a, hsa-miR-30a-5p, hsa-miR-375, and hsa-miR-486) that contribute to the prediction of T2DM remission in patients with coronary heart disease.

MiRNAs profile as biomarkers of nutritional therapy for the prevention of type 2 diabetes mellitus: From the CORDIOPREV study.

BACKGROUND AND AIM: The incidence of type 2 diabetes mellitus (T2DM) has increased worldwide. One of the first actions to reduce the risk of this disease is to implement healthy dietary models; however, no universal dietary strategies have so far been established. In addition, MicroRNAs (miRNAs) are emerging as new biomarkers to predict disease. We aimed to study whether miRNAs could be used to select the nutritional therapy to prevent T2DM development in patients with cardiovascular disease. METHODS: All patients from the CORDIOPREV study without T2DM at baseline according to the American Diabetes Association (ADA) diagnostic criteria (n = 462) were included in the present study. Of them, after a median dietary intervention period of 60 months with two diets (Low fat or Mediterranean diets), 107 developed T2DM and 355 subjects did not develop the disease. The plasma levels of 24 miRNAs were measured at baseline by qRT-PCR. The risk of T2DM was evaluated by Cox regression analysis based on the plasma levels of the miRNAs at baseline and according to the dietary intervention. Finally, pathways analyses were carried out to identify target genes regulated by the miRNAs studied and cellular processes which could be associated with T2DM development. RESULTS: Cox regression analyses showed that patients with low plasma levels of miR-145 at baseline showed a higher risk of developing T2DM after consumption of an LFHCC diet. In addition, patients with low levels of miR-29a, miR-28-3p and miR-126 and high plasma levels of miR-150 at baseline showed a higher risk of developing T2DM after consumption of the Med diet. Finally, pathways analysis showed an interaction of miR-126 and miR-29a in the modulation of FoxO, TNF-α, PI3K-AKT, p53 and mTOR signaling, associated with T2DM development. CONCLUSION: Our results suggest that circulating miRNAs could be used in clinical practice as a new tool for selecting the most suitable diet to prevent type 2 diabetes mellitus development in patients with cardiovascular disease. CLINICAL TRIALS NUMBER: NCT00924937.

"Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study".

OBJECTIVE: The vitamin D endocrine system may have a variety of actions on cells and tissues involved in COVID-19 progression especially by decreasing the Acute Respiratory Distress Syndrome. Calcifediol can rapidly increase serum 25OHD concentration. We therefore evaluated the effect of calcifediol treatment, on Intensive Care Unit Admission and Mortality rate among Spanish patients hospitalized for COVID-19. DESIGN: Parallel pilot randomized open label, double-masked clinical trial. SETTING: University hospital setting (Reina Sofia University Hospital, Córdoba Spain.) PARTICIPANTS: 76 consecutive patients hospitalized with COVID-19 infection, clinical picture of acute respiratory infection, confirmed by a radiographic pattern of viral pneumonia and by a positive SARS-CoV-2 PCR with CURB65 severity scale (recommending hospital admission in case of total score > 1). PROCEDURES: All hospitalized patients received as best available therapy the same standard care, (per hospital protocol), of a combination of hydroxychloroquine (400 mg every 12 h on the first day, and 200 mg every 12 h for the following 5 days), azithromycin (500 mg orally for 5 days. Eligible patients were allocated at a 2 calcifediol:1 no calcifediol ratio through electronic randomization on the day of admission to take oral calcifediol (0.532 mg), or not. Patients in the calcifediol treatment group continued with oral calcifediol (0.266 mg) on day 3 and 7, and then weekly until discharge or ICU admission. Outcomes of effectiveness included rate of ICU admission and deaths. RESULTS: Of 50 patients treated with calcifediol, one required admission to the ICU (2%), while of 26 untreated patients, 13 required admission (50 %) p value X2 Fischer test p < 0.001. Univariate Risk Estimate Odds Ratio for ICU in patients with Calcifediol treatment versus without Calcifediol treatment: 0.02 (95 %CI 0.002-0.17). Multivariate Risk Estimate Odds Ratio for ICU in patients with Calcifediol treatment vs Without Calcifediol treatment ICU (adjusting by Hypertension and T2DM): 0.03 (95 %CI: 0.003-0.25). Of the patients treated with calcifediol, none died, and all were discharged, without complications. The 13 patients not treated with calcifediol, who were not admitted to the ICU, were discharged. Of the 13 patients admitted to the ICU, two died and the remaining 11 were discharged. CONCLUSION: Our pilot study demonstrated that administration of a high dose of Calcifediol or 25-hydroxyvitamin D, a main metabolite of vitamin D endocrine system, significantly reduced the need for ICU treatment of patients requiring hospitalization due to proven COVID-19. Calcifediol seems to be able to reduce severity of the disease, but larger trials with groups properly matched will be required to show a definitive answer.

Aneurisma gigante de Arteria Cerebral Media: Trapping y By-Pass / Giant Aneurysm of the Middle Cerebral Artery: Trapping and By-Pass

Objetivo: Presentar la resolución quirúrgica de un aneurisma gigante de arteria cerebral media mediante técnica de Trapping y By-Pass. Introducción: La tasa de mortalidad a 5 años de pacientes con aneurismas gigantes es del 80%. Debido a su cuello ancho en ocasiones el clipado directo no es posible, requiriendo realizar Trapping del aneurisma seguido de revascularización mediante By-Pass. Material y Método: Se analizaron datos de historia clínica, imágenes complementarias pre y postquirúrgicas, así como imágenes de video intraoperatorias de un paciente portador de aneurisma gigante de arteria cerebral media intervenido en nuestro centro. Resultados: Mediante abordaje Pterional se localizó arteria temporal superficial y sus ramos. Luego de una cuidadosa disección del saco aneurismático se intentó el clipado primario, debido a su cuello ancho, aterosclerosis asociada y trombo intrasacular, el flujo en la rama temporal de arteria cerebral media era comprometido por el clip. Se decidió la oclusión del aneurisma mediante técnica de trapping y, en mismo tiempo quirúrgico, realización de By Pass extra-intracraneano de arteria temporal superficial a rama temporal de arteria cerebral media. A su vez se secciono el aneurisma y se removió el trombo contenido en su interior, logrando disminuir el efecto de masa ejercido por el mismo. Se corroboro permeabilidad intraquirurgica mediante Doppler y en el postoperatorio alejado mediante angiotomografía con reconstrucción 3D. El paciente evoluciono sin complicaciones asociadas con un Rankin modificado de 1. Conclusión: Se presentó resolución quirúrgica de aneurisma gigante de arteria cerebral media mediante técnica de Trapping seguida de By-Pass extra-intra craneano temporo-silviano

Objective: To present the surgical resolution of a giant aneurysm of the middle cerebral artery using Trapping and By-Pass technique. Introduction: The 5-year mortality rate of patients with giant aneurysms is 80%. Due to its wide neck, sometimes-direct clipping is not possible, requiring trapping of the aneu-rysm followed by bypass revascularization. Material and Method: Clinical history data and intraoperative video images of a pa-tient with a giant aneurysm of the middle cerebral artery were analyzed. Results: The superficial temporal artery and its branches were identified through a Pterional approach. After careful aneurysm dissection, primary clipping was attempted, but the flow in the temporal branch of the middle cerebral artery was compromised. Due to its wide neck, associated atherosclerosis and intrasaccular thrombus, an Extra-intracranial bypass was performed from superficial temporal artery to temporal branch of middle cerebral artery, followed by trapping technique of the aneurysm. Then the aneu-rysm was sectioned and the thrombus contained inside was removed, decreasing the mass effect exerted by it. A Doppler probe was used to corroborate bypass permeability, as well as 3D reconstruction angiotomography during the postoperative period. The pa-tient was discharged without associated complications and a modified Rankin scale of 1. Conclusion: Surgical resolution of a giant middle cerebral artery aneurysm was present-ed by Trapping technique followed by extra-intra-cranial temporo-Silvian bypass

Postprandial Lipemia Modulates Pancreatic Alpha-Cell Function in the Prediction of Type 2 Diabetes Development: The CORDIOPREV Study.

Diabetes (T2DM) is a major global health issue, and developing new approaches to its prevention is of paramount importance. We hypothesized that abnormalities in lipid metabolism are involved in alpha-cell deregulation. We therefore studied the metabolic factors underlying alpha-cell dysfunction in T2DM progression after a dietary intervention (Mediterranean and low-fat). Additionally, we evaluated whether postprandial glucagon levels may be considered as a predictive factor of T2DM in cardiovascular patients. Non-T2DM participants from the CORDIOPREV study were categorized by tertiles of the area under the curve (AUC) for triacylglycerols and also by tertiles of AUC for glucagon. Our results showed that patients with higher triacylglycerols levels presented elevated postprandial glucagon (P = 0.009). Moreover, we observed higher risk of T2DM (hazard ratio: 2.65; 95% confidence interval: 1.56-4.53) in subjects with elevated glucagon. In conclusion, high postprandial lipemia may induce alpha-cell dysfunction in cardiovascular patients. Our results also showed that postprandial glucagon levels could be used to predict T2DM development.

Long-term dietary adherence and changes in dietary intake in coronary patients after intervention with a Mediterranean diet or a low-fat diet: the CORDIOPREV randomized trial.

PURPOSE: Adherence to a healthy dietary pattern positively influences clinical outcomes in cardiovascular prevention, but long-term adherence is difficult to maintain. We evaluated 5-year changes in dietary habits, adherence achieved, and its maintenance in a cohort of coronary patients from the CORDIOPREV study. METHODS: 1002 coronary patients were randomized to a Mediterranean diet (n = 502) or a low-fat diet (n = 500) and received individual-group-telephone visits and personalized dietary advice. A validated food-frequency questionnaire, a 14-point Mediterranean diet adherence screener, and a 9-point low-fat diet adherence score were used. Dietary adherence was categorized into Low, Medium, and High Adherence. Changes in nutrient intake, food consumption, and adherence were analyzed on a yearly basis. The maintenance of long-term dietary adherence was evaluated using data after the first year and fifth year. RESULTS: From baseline to 5 years, significant increases were observed in overall dietary adherence (Mediterranean diet from 8.9 to 11.4; low-fat diet from 3.9 to 7.1) and in the percentage of patients considered High Adherence (Mediterranean diet from 41 to 89%; low-fat diet from 4 to 67%). When we evaluated the maintenance of adherence, patients considered Low and Medium Adherence at 1 year increased their adherence at the 5 years with both diets and patients considered High Adherence maintained their adherence with a Mediterranean diet, but decreased their adherence with a low-fat diet. CONCLUSIONS: A comprehensive dietary intervention results in an overall long-term improvement and maintenance of adherence to the Mediterranean and low-fat diets. In our population, the Mediterranean diet group achieved a high level of adherence in the short term which was maintained in the long term.

Tratamiento de tumores de piel con SENSUS SRT-100TM en el Centro Oncológico Pinareño / Treatment of skin tumors with SENSUS SRT-100TM at Cancer Treatment Center of Pinar del Río

RESUMEN Introducción: al atender la alta incidencia de cáncer cutáneo no melanómico, donde son utilizados tratamientos con radiaciones ionizantes, en específico con el equipo SENSUS SRT-100TM, en el Centro de Atención al Paciente Oncológico de Pinar del Río, y dada la necesidad de usar con eficacia prestaciones relacionadas con esta práctica; se realizó un estudio observacional retrospectivo para discutir sobre el uso de aspectos relacionados con el paciente, sus lesiones, administración y aprovechamiento de la máquina de tratamiento, con vistas a incrementar los beneficios en esta terapia. Objetivo: realizar un estudio observacional retrospectivo con los tratamientos de radioterapia superficial, con la utilización del equipo SENSUS SRT-100TM, que muestre la necesidad del uso de criterios apropiados con vistas a incrementar la calidad del servicio y eficacia en el aprovechamiento de los recursos. Métodos: se utilizó el método observacional retrospectivo, con el universo de pacientes tratados mediante radioterapia superficial Resultados: el 60,3 % había recibido algún tratamiento previo en al menos una de sus lesiones. El 77,8 % presentaron riesgo intermedio o alto de recurrencia de la enfermedad y el 65 % de los esquemas estuvieron dentro de la ventana terapéutica recomendada de TDFs. El aprovechamiento de la máquina resultó ser bajo. Conclusiones: incrementar el uso de criterios apropiados y fortalecer la formación de especialidades encargadas con estos tratamientos, elevaría la calidad de los mismos y eficacia en el aprovechamiento de los recursos.

ABSTRACT Introduction: considering the high incidence of non-melanomic skin cancer, where treatments with ionizing radiations are used, specifically with the SENSUS SRT-100TM equipment at Cancer Treatment Center of Pinar del Río, and given the need to effectively apply the benefits related to this practice, a retrospective observational study was conducted to discuss the use of aspects related to patients, lesions, administration and application of the treatment machine with a view to increase the benefits of this therapy. Objective: to conduct a retrospective observational study with superficial radiotherapy treatment using SENSUS SRT-100TM equipment, showing the need for the use of the appropriate criteria in order to increase the quality of the service and its efficiency making good use of the resources. Methods: the retrospective observational method was applied, with the target group of patients treated with superficial radiotherapy. Results: 60.3% had received some previous treatment in at least one of their lesions. The 77.8% presented intermediate or high risk of recurrence of the disease and 65% of the schemes were within the recommended therapeutic window of Time-Dose-Fractionation Factors (TDFs). Machine utilization turned out to be low. Conclusions: increasing the use of appropriate criteria and strengthening the training of specialties entrusted with these treatments could improve their quality and efficiency in the use of resources.

Apolipoprotein E genetic variants interact with Mediterranean diet to modulate postprandial hypertriglyceridemia in coronary heart disease patients: CORDIOPREV study.

BACKGROUND: We try to explore whether long-term consumption of two healthy dietary patterns (low-fat [LF] diet or Mediterranean diet [MedDiet]) interacts with the apolipoprotein E (APOE) single-nucleotide polymorphisms (SNPs: rs439401, rs440446 and rs7412) modulating postprandial hypertriglyceridemia (ppHTG) in coronary heart disease (CHD) patients. METHODS AND RESULTS: We selected patients from the CORDIOPREV study with genotyping and who underwent an oral fat load test (FLT) at baseline and after 3 years follow-up (n = 506). After 3 years of follow-up, we found a gene-diet interaction between the APOE rs439401 SNP and MedDiet. Specifically, T-allele carriers in the MedDiet group showed a more significant decrease in postprandial triglycerides (TG: P = 0.03) and large triacylglycerol-rich lipoproteins (TRLs) TG (large TRLs TG; P = 0.01) compared with CC subjects. Consistently, the area under the curve of TG (AUC-TG; P-interaction = 0.03) and AUC-large TRLs TG (P-interaction = 0.02) were significantly lower in T-allele carriers compared with CC subjects. CONCLUSIONS: The long-term consumption of a MedDiet modulates ppHTG through APOE genetic variants in CHD patients. This gene-diet interaction may contribute to a more precise dietary advice in CHD patients.

Utilidad de las Escalas de Gradación en el Tratamiento Quirúrgico de Malformaciones Arteriovenosas Cerebrales / Usefulness of the Gradation Scales in the Surgical Treatment of Cerebral Arteriovenous Malformations

Introducción: Las malformaciones arteriovenosas (MAVs) cerebrales comprenden una compleja patología responsable de hasta el 38% de las hemorragias en pacientes de entre 15-45 años, acarreando cada episodio de sangrado un 25-50% de morbilidad y un 10-20% de mortalidad. La decisión terapéutica en un paciente con una MAV debe tener en cuenta la comparación entre los riesgos propios de la intervención y los de la historia natural de esta enfermedad. Objetivo: Evaluar la utilidad de predecir riesgo quirúrgico de diferentes escalas de gradación de MAV cerebrales según nuestra experiencia en una serie de casos. Material y Métodos: Se realizó un análisis bibliográfico de escalas de gradación de riesgo quirúrgico de MAV cerebrales utilizando como motor de búsqueda Pubmed incluyendo como palabras clave "malformación arteriovenosa cerebral" y "escala de gradación" (brain arteriovenous and malformation grading scale). Se analizaron de forma retrospectiva aquellos pacientes intervenidos quirúrgicamente por MAV en este hospital público, se las clasificó acorde a las escalas analizadas y se compararon los resultados obtenidos con los previstos en ellas. Resultados: Se analizaron 90 pacientes intervenidos quirúrgicamente por MAV, sin tratamiento coadyuvante. De forma retrospectiva se los agrupó acorde a las escalas de Spetzler Martin (SM), Spetzler-Ponce (SP) y suplementaria de Lawton. Las MAV grado 3 se subclasificaron según las escalas de Lawton y de de Oliveira. Considerando buenos resultados aquellos con Rankin modificado (mRs) igual o menor a 2. Con un rango de seguimiento de 12 a 48 meses, encontramos buenos resultados en el 100% de MAV SM grado 1, 91.7% de las grado 2, 80% en grado 3 y 42.9% en grado 4. Utilizando la escala SP, 93.7% de buenos resultados en tipo A, 80% en tipo B y 42.9% en tipo C. Subclasifican-do las MAV SM 3 acorde a las escalas de de Oliveira y Lawton, 84% de buenos resultados en el tipo 3A, 71.3% en las 3B, 92% en MAV tipo 3-, 72.1% en el tipo 3+, 60% en tipo 3. Utilizando la escala suplementaria de Lawton combinada con SM, buen resultado en 100% grados II y III, 85,7% grado IV, 87,6 grado V, 80% grado VI, 75% grado VII y 66,6% grado VIII. Conclusión: Reafirmamos en esta serie, la utilidad de estimar riesgo quirúrgico con las escalas SM, SP, y la subclasificación de las MAV grado 3 propuesta por Lawton. Y principalmente el utilizar la escala suplementaria de Lawton-Young al considerar el tratamiento quirúrgico de los pacientes con MAV que sangraron.

Introduction: Brain arteriovenous malformations (AVM) are a complex disease responsible for up to 38% of hemorrhages in patients between 15-45 years old, carrying every bleeding episode a 25-50% risk of morbidity and a 10-20% of mortality. The therapeutic decision in a patient with an AVM needs to consider both the risks of the intervention and the risks of the natural evolution of the disease. Objective: To assess the effectiveness of different AVM grading scales in predicting surgical risks according to our experience in a case series. Material and Method: a literature review of the AVM grading scales was made, through Pubmed including as key words "brain arteriovenous malformations" and "grading scale". A retrospective analysis was made of patients with AVM who were operated in our institution, they were classified according to the scales and their results were compared. Results: 90 patients were operated in our institution with AVM. Retrospectively, they were classified according to the Spetzler-Martin (SM), Spetzler-Ponce (SP), Lawton supplementary, and the sub-classifications in AVM grade 3, from Lawton and de Oliveira. Good outcome were considered when modified Rankin Scale (mRs) was equal or less than 2. The follow-up ranged from 12-48 months, having good outcome in 100% of AVM SM grade I, 91,7% grade II, 80% in grade III and 42,9% in grade IV. Using the SP scale, 93,7% of good outcome in grade A, 80% in grade B and 42,9% in grade C. In the sub-classification of AVM SM 3, we found 84% of good outcome in type 3A de Oliveira and 71,3% in type 3B. According to the Lawton scale, good outcome were found in 92% in type 3-, 72,1% in type 3+ and 60% in type 3. Using Lawton supplementary scale combined with SM, there were 100% of good outcome in grades II and III, 85,7% in grade IV, 87,6% in grade V, 80% in grade VI, 75% in grade VII, 66,6% in grade VIII. Conclusion: In our series, we reaffirm the effectiveness to predict surgical risk of the following scales: SM, SP and the Lawton's sub-classification of AVM grade 3. Specially, the use of the supplementary Lawton-Young scale in the surgical treatment of bleeding AVMs.

[Usefulness of Gradation Scales in the Surgical Treatment of Cerebral Arteriovenous Malformations]. / Utilidad de las Escalas de Gradación en el Tratamiento Quirúrgico de Malformaciones Arteriovenosas Cerebrales.

INTRODUCTION: Brain arteriovenous malformations (AVM) are a complex disease responsible for up to 38% of hemorrhages in patients between 15-45 years old, carrying every bleeding episode a 25-50% risk of morbidity and a 10-20% of mortality. The therapeutic decision in a patient with an AVM needs to consider both the risks of the intervention and the risks of the natural evolution of the disease. OBJECTIVE: To assess the effectiveness of different AVM grading scales in predicting surgical risks according to our experience in a case serie. MATERIAL AND METHOD: A literature review of the AVM grading scales was made, through Pubmed including as key words "brain arteriovenous malformations" and "grading scale". A retrospective analysis was made of patients with AVM who were operated in our institution, they were classified according to the scales and their results were compared. RESULTS: 90 patients were operated in our institution with AVM. Retrospectively, they were classified according to the Spetzler-Martin (SM), Spetzler-Ponce (SP), Lawton supplementary, and the sub-classifications in AVM grade 3, from Lawton and de Oliveira. Good outcome were considered when modified Rankin Scale (mRs) was equal or less than 2. The follow-up ranged from 12-48 months, having good outcome in 100% of AVM SM grade I, 91,7% grade II, 80% in grade III and 42,9% in grade IV. Using the SP scale, 93,7% of good outcome in grade A, 80% in grade B and 42,9% in grade C. In the sub-classification of AVM SM 3, we found 84% of good outcome in type 3A de Oliveira and 71,3% in type 3B. According to the Lawton scale, good outcome were found in 92% in type 3-, 72,1% in type 3+ and 60% in type 3. Using Lawton supplementary scale combined with SM, there were 100% of good outcome in grades II and III, 85,7% in grade IV, 87,6% in grade V, 80% in grade VI, 75% in grade VII, 66,6% in grade VIII. CONCLUSION: In our serie, we reaffirm the effectiveness to predict surgical risk of the following scales: SM, SP and the Lawton's sub-classification of AVM grade 3. Specially, the use of the supplementary Lawton-Young scale in the surgical treatment of bleeding AVMs.

Low Intake of Vitamin E Accelerates Cellular Aging in Patients With Established Cardiovascular Disease: The CORDIOPREV Study.

Leukocyte telomere length (LTL) shortening is a biomarker of cellular aging that can be decelerated by diet. We aimed to investigate the effect of dietary intake of vitamin E on biomarkers of cellular senescence in patients with established cardiovascular disease. To this end, DNA from 1,002 participants of the CORDIOPREV study (NCT00924937) was isolated and LTL was measured by real-time PCR. Dietary information was collected using a 146-item food frequency questionnaire, and several oxidative stress and damage biomarkers were determined. We found that patients with an inadequate intake of vitamin E according to the European Food Safety Authority, U.S. Food and Nutrition Board, and Spanish dietary recommendation had shorter LTL than those with an adequate intake (p = .004, p = .015, and p = .005, respectively). Moreover, we observed a positive correlation between olive oil, fish consumption and LTL (r2 = .083, p = .010; r2 = .090, p = .006, respectively). Subjects who consumed more than 30 mL olive oil/day had longer LTL than subjects with lower consumption (p = .013). Furthermore, we observed higher glutathione peroxidase activity in subjects consuming less vitamin E (p = .031). Our findings support the importance of an adequate consumption of the antioxidant vitamin E, and the value of the diet as a modulating tool of the senescence process.

Estudio del riesgo en radioterapia superficial con SENSUS SRT-100TM usando FMEA y código SECURE MR-FMEA / Study of risks in superficial radiotherapy with SENSUS SRT-100TM using FMEA and code SECURE MR-FMEA

RESUMEN Introducción: atendiendo a la alta incidencia de cáncer cutáneo, donde son utilizados tratamientos con radiaciones ionizantes, específicamente con equipo SENSUS SRT-100TM en el Centro de Atención al Paciente Oncológico de Pinar del Río y dada la necesidad de mejorar la prevención de incidentes y accidentes relacionados con la práctica, se ha empleado un enfoque avanzado de análisis de riesgo similar al propuestos por la Asociación Americana de Físicos Médicos a través del uso del software SECURE MR-FMEA. Objetivo: desarrollar un estudio de riesgo para radioterapia superficial con SENSUS SRT 100TM que identifique los modos y causas de fallos asociados al tratamiento, que posibiliten el empleo de aplicaciones que optimicen la seguridad y calidad de la práctica. Métodos: se utilizó el método prospectivo de análisis de modos y efectos de fallos a tratamientos superficiales con SENSUS SRT-100TM mediante aplicaciones desarrolladas en el código SECURE MR-FMEA. Resultados: se diseñó el mapa del proceso con sus subprocesos y etapas respectivas por un equipo multidisciplinario formado en el Centro de Atención al Paciente Oncológico pinareño, propiciando la comprensión global de la actividad y determinación del perfil de riesgo y árboles de fallos de interés (apoyado en prestaciones del programa SECURE MR-FMEA) creándose así, medidas de defensa y desarrollándose actividades que disminuyeron el riesgo tras reevaluación efectuada. Conclusiones: el estudio de riesgo realizado en radioterapia superficial posibilitó fortalecer la seguridad y calidad de los tratamientos administrados en el Centro de Atención al Paciente Oncológico de Pinar del Río, además de facilitar futuras evaluaciones.

ABSTRACT Introduction: in view of the high incidence of skin cancer, where treatments with ionizing radiation are used, particularly with SENSUS SRT-100TM equipment at Oncology Patient Care Center of Pinar del Río, and the known need to improve the prevention of incidents and accidents related to this practice, an advanced risk-analysis approach, similar to that proposed by the American Association of Physicists in Medicine, was applied using the SECURE MR-FMEA code. Objective: to develop a risk study for superficial radiotherapy with SENSUS SRT 100TM that identifies the modes and causes of failures associated with the treatment, which allow the use of applications that optimize the safety and quality of the practice. Methods: the prospective method of failure modes and effect analysis, regarding superficial treatments with SENSUS SRT-100TM through the applications developed by means of the SECURE MR-FMEA code. Results: the process map was designed with its sub-processes and respective stages by a multidisciplinary team created at Oncology Patient Care Center in Pinar del Río, assisting the global comprehension of the activity and determining the risk profile and specific failure trees (supported by the benefits of the SECURE MR-FMEA program), to create defense measures and developing activities that decreased the risk after the application of the reassessment. Conclusions: the risk study carried out in superficial radiotherapy made possible to strengthen the safety and quality of the treatments delivered at the Oncology Patient Care Center of Pinar del Río, allowing the future assessments.

Circulating miRNAs as Predictive Biomarkers of Type 2 Diabetes Mellitus Development in Coronary Heart Disease Patients from the CORDIOPREV Study.

Circulating microRNAs (miRNAs) have been proposed as type 2 diabetes biomarkers, and they may be a more sensitive way to predict development of the disease than the currently used tools. Our aim was to identify whether circulating miRNAs, added to clinical and biochemical markers, yielded better potential for predicting type 2 diabetes. The study included 462 non-diabetic patients at baseline in the CORDIOPREV study. After a median follow-up of 60 months, 107 of them developed type 2 diabetes. Plasma levels of 24 miRNAs were measured at baseline by qRT-PCR, and other strong biomarkers to predict diabetes were determined. The ROC analysis identified 9 miRNAs, which, added to HbA1c, have a greater predictive value in early diagnosis of type 2 diabetes (AUC = 0.8342) than HbA1c alone (AUC = 0.6950). The miRNA and HbA1c-based model did not improve when the FINDRISC was included (AUC = 0.8293). Cox regression analyses showed that patients with low miR-103, miR-28-3p, miR-29a, and miR-9 and high miR-30a-5p and miR-150 circulating levels have a higher risk of disease (HR = 11.27; 95% CI = 2.61-48.65). Our results suggest that circulating miRNAs could potentially be used as a new tool for predicting the development of type 2 diabetes in clinical practice.

Beneficial effect of CETP gene polymorphism in combination with a Mediterranean diet influencing lipid metabolism in metabolic syndrome patients: CORDIOPREV study.

The cholesteryl ester transfer protein (CETP) gene has been implicated in high-density lipoprotein (HDL-C) metabolism. However, little is known about the impact of this gene on metabolic syndrome (MetS) patients and its interaction with diet. Here, we evaluate whether the consumption of a Mediterranean diet, compared with a Low-fat diet, interacts with the rs3764261 SNP at the CETP locus to modify lipid metabolism in MetS patients. Plasma lipid concentrations and rs3764261 genotypes were determined in 424 MetS subjects participating in the CORDIOPREV clinical trial (NCT00924937). Gene-diet interactions were analyzed after a year of dietary intervention (Mediterranean diet (35% fat, 22% MUFA) vs Low-fat diet (28% fat, 12% MUFA)). We found significant gene-diet interactions between rs3764261 SNP and the dietary pattern for HDL-C (P = 0.006) and triglyceride concentrations (P = 0.040). Specifically, after 12 months of Mediterranean diet intervention, subjects who were carriers of the minor T allele (TT + TG) displayed higher plasma HDL-C concentrations (P = 0.021) and lower triglycerides (P = 0.020) compared with those who were homozygous for the major allele (GG). In contrast, in the Low-fat intervention group, no significant differences were found between CETP genotypes after 12 months of dietary treatment. Our data support the notion that the consumption of a Mediterranean diet may play a contributing role in triggering lipid metabolism by interacting with the rs3764261 SNP at CETP gene locus in MetS patients. Due to the complex nature of gene-environment interactions, dietary adjustment in MetS patients may require a personalized approach.

Telomerase RNA Component Genetic Variants Interact With the Mediterranean Diet Modifying the Inflammatory Status and its Relationship With Aging: CORDIOPREV Study.

Background: Leukocyte telomere length (LTL) attrition has been associated with age-related diseases. Telomerase RNA Component (TERC) genetic variants have been associated with LTL; whereas fatty acids (FAs) can interact with genetic factors and influence in aging. We explore whether variability at the TERC gene locus interacts with FA profile and two healthy diets (low-fat diet vs Mediterranean diet [MedDiet]) modulating LTL, glucose metabolism, and inflammation status in coronary heart disease (CHD) patients. Methods: Inflammation status (high-sensitivity C-reactive protein [hsCRP], glucose metabolism-glucose, insulin, and glycated hemoglobin [HbA1c], and homeostasis model assessment of insulin resistance [HOMA-IR]), LTL, FAs, and single nucleotide polymorphisms (SNPs) of the TERC gene (rs12696304, rs16847897, and rs3772190) were determined in 1,002 patients from the CORDIOPREV study (NCT00924937). Results: We report an interaction of the TERC rs12696304 SNP with monounsaturated fatty acid (MUFA) affecting LTL (p interaction = .01) and hsCRP (p interaction = .03). Among individuals with MUFA levels above the median, CC individuals showed higher LTL and lower hsCRP than G-allele carriers. Moreover, MedDiet interacted with TERC rs12696304 SNP (p interaction = .03). Specifically, CC individuals displayed a greater decrease in hsCRP than G-allele carriers. These results were not adjusted for multiple statistical testing and p less than .05 was considered significant. Conclusions: Our findings suggest that the TERC rs12696304 SNP interacts with MUFA improving inflammation status and telomere attrition related with CHD. Moreover, the MedDiet intervention improves the inflammatory profile in CC individuals compared with the G-allele carriers. These interactions could provide a right strategy for personalized nutrition in CHD patients.